23andMe says TTAM Research Institute, a nonprofit backed by Anne Wojcicki, is the new buyer for the company's assets, offering $305M and topping Regeneron's bid
Wall Street Journal :
Regeneron Pharmaceuticals says it will acquire 23andMe's assets, including its Personal Genome Service, for $256M, set to close in Q3, in the bankruptcy auction
But What Happens to Your Data? David Braue / Information Age : Biotech buys bankrupt DNA data firm 23andMe for $400m Naomi Li Gan / Tech in Asia : Pharma giant Regeneron to buy genetics firm 23andMe f...
Regeneron Pharmaceuticals says it will acquire 23andMe's assets, including its Personal Genome Service, for $256M, set to close in Q3, in the bankruptcy auction
Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe's assets — Regeneron Pharmaceuticals …
A special committee of 23andMe's board says it's not “prepared to move forward” with CEO Anne Wojcicki's $0.40-per-share offer to take the company private
A special committee of 23andMe's board said it's not “prepared to move forward” with Chief Executive Officer Anne Wojcicki's offer … X: @carnage4life X: Dare Obasanjo / @carnage4life : 23andMe's board...
Filing: 23andMe CEO Anne Wojcicki is seeking to take 23andMe private after three years that saw its valuation collapse from a high of $6B to ~$200M on April 17
Rolfe Winkler / Wall Street Journal :